These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 29752431)

  • 1. DDB2 represses ovarian cancer cell dedifferentiation by suppressing ALDH1A1.
    Cui T; Srivastava AK; Han C; Wu D; Wani N; Liu L; Gao Z; Qu M; Zou N; Zhang X; Yi P; Yu J; Bell EH; Yang SM; Maloney DJ; Zheng Y; Wani AA; Wang QE
    Cell Death Dis; 2018 May; 9(5):561. PubMed ID: 29752431
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High NRF2 level mediates cancer stem cell-like properties of aldehyde dehydrogenase (ALDH)-high ovarian cancer cells: inhibitory role of all-trans retinoic acid in ALDH/NRF2 signaling.
    Kim D; Choi BH; Ryoo IG; Kwak MK
    Cell Death Dis; 2018 Aug; 9(9):896. PubMed ID: 30166520
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeting aldehyde dehydrogenase cancer stem cells in ovarian cancer.
    Landen CN; Goodman B; Katre AA; Steg AD; Nick AM; Stone RL; Miller LD; Mejia PV; Jennings NB; Gershenson DM; Bast RC; Coleman RL; Lopez-Berestein G; Sood AK
    Mol Cancer Ther; 2010 Dec; 9(12):3186-99. PubMed ID: 20889728
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CD166 promotes the cancer stem-like properties of primary epithelial ovarian cancer cells.
    Kim DK; Ham MH; Lee SY; Shin MJ; Kim YE; Song P; Suh DS; Kim JH
    BMB Rep; 2020 Dec; 53(12):622-627. PubMed ID: 32843129
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MUC1-C oncoprotein activates ERK→C/EBPβ signaling and induction of aldehyde dehydrogenase 1A1 in breast cancer cells.
    Alam M; Ahmad R; Rajabi H; Kharbanda A; Kufe D
    J Biol Chem; 2013 Oct; 288(43):30892-903. PubMed ID: 24043631
    [TBL] [Abstract][Full Text] [Related]  

  • 6. DDB2 suppresses tumorigenicity by limiting the cancer stem cell population in ovarian cancer.
    Han C; Zhao R; Liu X; Srivastava A; Gong L; Mao H; Qu M; Zhao W; Yu J; Wang QE
    Mol Cancer Res; 2014 May; 12(5):784-94. PubMed ID: 24574518
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ALDH1A1+ ovarian cancer stem cells co-expressing surface markers CD24, EPHA1 and CD9 form tumours in vivo.
    Nagare RP; Sneha S; Krishnapriya S; Ramachandran B; Murhekar K; Vasudevan S; Shabna A; Ganesan TS
    Exp Cell Res; 2020 Jul; 392(1):112009. PubMed ID: 32305326
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of
    Nowacka M; Ginter-Matuszewska B; Świerczewska M; Sterzyńska K; Nowicki M; Januchowski R
    Int J Mol Sci; 2022 Mar; 23(6):. PubMed ID: 35328460
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stem cell pathways contribute to clinical chemoresistance in ovarian cancer.
    Steg AD; Bevis KS; Katre AA; Ziebarth A; Dobbin ZC; Alvarez RD; Zhang K; Conner M; Landen CN
    Clin Cancer Res; 2012 Feb; 18(3):869-81. PubMed ID: 22142828
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ALDH1A1 maintains ovarian cancer stem cell-like properties by altered regulation of cell cycle checkpoint and DNA repair network signaling.
    Meng E; Mitra A; Tripathi K; Finan MA; Scalici J; McClellan S; Madeira da Silva L; Reed E; Shevde LA; Palle K; Rocconi RP
    PLoS One; 2014; 9(9):e107142. PubMed ID: 25216266
    [TBL] [Abstract][Full Text] [Related]  

  • 11. ALDH1A1 is a novel EZH2 target gene in epithelial ovarian cancer identified by genome-wide approaches.
    Li H; Bitler BG; Vathipadiekal V; Maradeo ME; Slifker M; Creasy CL; Tummino PJ; Cairns P; Birrer MJ; Zhang R
    Cancer Prev Res (Phila); 2012 Mar; 5(3):484-91. PubMed ID: 22144423
    [TBL] [Abstract][Full Text] [Related]  

  • 12. TAZ induces lung cancer stem cell properties and tumorigenesis by up-regulating ALDH1A1.
    Yu J; Alharbi A; Shan H; Hao Y; Snetsinger B; Rauh MJ; Yang X
    Oncotarget; 2017 Jun; 8(24):38426-38443. PubMed ID: 28415606
    [TBL] [Abstract][Full Text] [Related]  

  • 13. DDB2 modulates TGF-β signal transduction in human ovarian cancer cells by downregulating NEDD4L.
    Zhao R; Cui T; Han C; Zhang X; He J; Srivastava AK; Yu J; Wani AA; Wang QE
    Nucleic Acids Res; 2015 Sep; 43(16):7838-49. PubMed ID: 26130719
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Application of AlDeSense to Stratify Ovarian Cancer Cells Based on Aldehyde Dehydrogenase 1A1 Activity.
    Lee MC; Gardner SH; Tapia Hernandez R; Chan J
    J Vis Exp; 2023 Mar; (193):. PubMed ID: 37067271
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Loss of ALDH1A1 expression is an early event in the pathogenesis of ovarian high-grade serous carcinoma.
    Chui MH; Wang Y; Wu RC; Seidman J; Kurman RJ; Wang TL; Shih IeM
    Mod Pathol; 2015 Mar; 28(3):437-45. PubMed ID: 25216223
    [TBL] [Abstract][Full Text] [Related]  

  • 16. β-Catenin-regulated ALDH1A1 is a target in ovarian cancer spheroids.
    Condello S; Morgan CA; Nagdas S; Cao L; Turek J; Hurley TD; Matei D
    Oncogene; 2015 Apr; 34(18):2297-308. PubMed ID: 24954508
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lusianthridin targeting of lung cancer stem cells via Src-STAT3 suppression.
    Bhummaphan N; Petpiroon N; Prakhongcheep O; Sritularak B; Chanvorachote P
    Phytomedicine; 2019 Sep; 62():152932. PubMed ID: 31100681
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Low expression of aldehyde dehydrogenase 1A1 (ALDH1A1) is a prognostic marker for poor survival in pancreatic cancer.
    Kahlert C; Bergmann F; Beck J; Welsch T; Mogler C; Herpel E; Dutta S; Niemietz T; Koch M; Weitz J
    BMC Cancer; 2011 Jun; 11():275. PubMed ID: 21708005
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of ALDH1A1 activity decreases expression of drug transporters and reduces chemotherapy resistance in ovarian cancer cell lines.
    Januchowski R; Wojtowicz K; Sterzyſska K; Sosiſska P; Andrzejewska M; Zawierucha P; Nowicki M; Zabel M
    Int J Biochem Cell Biol; 2016 Sep; 78():248-259. PubMed ID: 27443528
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Co-expression of cancer stem cell markers, SALL4/ALDH1A1, is associated with tumor aggressiveness and poor survival in patients with serous ovarian carcinoma.
    Sharbatoghli M; Shamshiripour P; Fattahi F; Kalantari E; Habibi Shams Z; Panahi M; Totonchi M; Asadi-Lari Z; Madjd Z; Saeednejad Zanjani L
    J Ovarian Res; 2022 Jan; 15(1):17. PubMed ID: 35090523
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.